Steven M. Fruchtman
2021
In 2021, Steven M. Fruchtman earned a total compensation of $2.7M as President and Chief Executive Officer at Onconova Therapeutics, a 159% increase compared to previous year.
Compensation breakdown
| Bonus | $279,750 |
|---|---|
| Option Awards | $509,079 |
| Salary | $600,000 |
| Stock Awards | $1,261,685 |
| Other | $23,699 |
| Total | $2,674,213 |
Fruchtman received $1.3M in stock awards, accounting for 47% of the total pay in 2021.
Fruchtman also received $279.8K in bonus, $509.1K in option awards, $600K in salary and $23.7K in other compensation.
Rankings
In 2021, Steven M. Fruchtman's compensation ranked 4,882nd out of 12,415 executives tracked by ExecPay. In other words, Fruchtman earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,882 out of 12,415 | 61st |
Division Manufacturing | 2,043 out of 5,505 | 63rd |
Major group Chemicals And Allied Products | 865 out of 2,375 | 64th |
Industry group Drugs | 775 out of 2,096 | 63rd |
Industry Pharmaceutical Preparations | 553 out of 1,546 | 64th |
Source: SEC filing on May 25, 2022.
Fruchtman's colleagues
We found two more compensation records of executives who worked with Steven M. Fruchtman at Onconova Therapeutics in 2021.
News
Onconova Therapeutics CEO Steven Fruchtman's 2023 pay slips 17% to $1.1M
October 11, 2024
Onconova Therapeutics CEO Steven Fruchtman's 2022 pay falls 50% to $1.3M
June 7, 2023
Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
May 25, 2022
Onconova Therapeutics CEO Ramesh Kumar's 2018 pay jumps 82% to $1.2M
April 29, 2019